Key Highlights:

• Proteomics International shares surged 28.13% during Friday’s trading session.

• The company continues advancing its precision diagnostics and proteomics technology platform.

• Recent activities remain focused on commercialisation, regulatory progress and expanding international opportunities.

• Investors continue monitoring product adoption, regulatory milestones and commercial partnerships.

Proteomics International Laboratories Ltd (ASX: PIQ) attracted significant investor attention on Friday after its share price surged 28.13% to AUD 0.20. The sharp rally highlights renewed market interest in healthcare and biotechnology companies as investors continue assessing…